Igor Tartakovsky
Boehringer Ingelheim (Germany)(DE)Boehringer Ingelheim (Portugal)(PT)
Publications by Year
Research Areas
Venous Thromboembolism Diagnosis and Management, Blood Coagulation and Thrombosis Mechanisms, Legionella and Acanthamoeba research, Listeria monocytogenes in Food Safety, Cardiac Arrhythmias and Treatments
Most-Cited Works
- → Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial(2020)137 cited
- → Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children(2019)90 cited
- → Efficacy and tolerability of Ginkgo biloba extract EGb 761® by type of dementia: Analyses of a randomised controlled trial(2009)79 cited
- → Global Use of Idarucizumab in Clinical Practice: Outcomes of the RE-VECTO Surveillance Program(2019)47 cited
- → Phase IIa study of dabigatran etexilate in children with venous thrombosis: pharmacokinetics, safety, and tolerability(2017)34 cited
- → Antimicrobial Resistance of Listeria monocytogenes Strains Isolated from Humans, Animals, and Food Products in Russia in 1950–1980, 2000–2005, and 2018–2021(2021)31 cited